Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Yiyang Biological Technology is a biotechnology company based in Guangzhou, China, that specializes in the field of regenerative medicine and cell therapy. The company focuses on the research and development of stem cell and immune cell technologies, providing comprehensive services including cell storage, processing, and health management. Their primary research interests involve the application of mesenchymal stem cells (MSCs) and natural killer (NK) cells for treating chronic diseases and age-related conditions. Operating out of the Guangzhou High-tech Zone, the firm maintains advanced laboratory facilities to support its clinical translation efforts. Yiyang Biological aims to integrate cutting-edge biotechnology with clinical practice to improve patient outcomes in immunology and orthopedics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Yiyang Biological Technology.